Your session is about to expire
← Back to Search
Behavioural Intervention
CranioSacral Therapy for Parkinson's Disease
N/A
Waitlist Available
Led By Al Raza, CST
Research Sponsored by Zia, Al Raza
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with Parkinson's Disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial is studying the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients. This therapy is given biweekly for 3 months, and the investigators expect to see a positive change in the symptoms of the patients.
Who is the study for?
This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.Check my eligibility
What is being tested?
The study is testing the effects of CranioSacral Integrative Therapy on patients with Parkinson's Disease over a period of 3 months, involving biweekly therapy sessions lasting 90 minutes each.See study design
What are the potential side effects?
Since CranioSacral Integrative Therapy is a manual therapeutic approach, potential side effects may include discomfort or mild pain during or after treatment, headache, fatigue, or emotional release.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Parkinson's Disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
reduction in tremors due to Parkinson's disease in the patient
Secondary outcome measures
Quality of Proprioception
Other outcome measures
Overall emotional State and sleep quality
Trial Design
1Treatment groups
Experimental Treatment
Group I: biweekly interventionExperimental Treatment1 Intervention
biweekly intervention
Find a Location
Who is running the clinical trial?
Zia, Al RazaLead Sponsor
Al Raza, CSTPrincipal InvestigatorIBR, Inc.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with Parkinson's Disease.I do not have Parkinson's Disease.
Research Study Groups:
This trial has the following groups:- Group 1: biweekly intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any recruitment opportunities still available for this investigation?
"According to clinicaltrials.gov, this medical trial is no longer recruiting participants and was last updated on July 15th 2021 after being first posted in February 2014. However, there are 488 other trials that are actively searching for patients at the moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger